See also this year's filing and all EDGAR filings for this company.
PDF Report 0001159019_2012_Tribute_Pharmaceuticals_Canada_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001159019, Tribute Pharmaceuticals Canada Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,182,488 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 13,818,485 |
| 2 | PropertyPlantAndEquipmentNet | 1,207,462 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 4,311,374 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,524,200 |
| 7 | CostOfGoodsAndServicesSold | 932,755 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,034,740 |
| 9 | ResearchAndDevelopmentExpense | 49,977 |
| 10 | remainder_Expenses | 289,748 |
| 11 | remainder_Revenues | 3,888,791 |
| 12 | remainder_NetIncome | -103,352 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 19,208,435 |
| 1 | Liabilities | 5,835,574 |
| 2 | Expenses | 4,307,220 |
| 3 | Revenues | 3,888,791 |
| 4 | StockholdersEquity | 13,372,861 |
| 5 | NetIncome | -521,781 |
| 6 | ComprehensiveNetIncome | -521,781 |
| 7 | BaseVar | 16,671,686 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.29 |
| 9 | EconomicCapitalRatio | 3.21 |
Edgar->Model Mapping
Feature Distribution
